U. Seker Et Al. , "Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways," ANDROLOGIA , 2022
Seker, U. Et Al. 2022. Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways. ANDROLOGIA .
Seker, U., Kavak, D. E., Guzel, B. C., BAYGELDİ, S. B., YÜKSEL, M., Demirel, O. U., ... Kandemir, S. I.(2022). Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways. ANDROLOGIA .
Seker, Ugur Et Al. "Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways," ANDROLOGIA , 2022
Seker, Ugur Et Al. "Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways." ANDROLOGIA , 2022
Seker, U. Et Al. (2022) . "Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways." ANDROLOGIA .
@article{article, author={Ugur Seker Et Al. }, title={Targeting soluble guanylate cyclase with Riociguat has potency to alleviate testicular ischaemia reperfusion injury via regulating various cellular pathways}, journal={ANDROLOGIA}, year=2022}